1.A Case of Myeloid Blast Crisis of Ph-positive Chronic Myeloid Leukemia with t(3;21)(q26;q22).
Gui Jeon CHOI ; Hyo Jin CHUN ; Dong Seok JEON ; Jae Ryong KIM ; Ki Young KWON
Korean Journal of Clinical Pathology 1997;17(1):21-27
The t(3;21) (q26;q22) is associated with chronic myelogenous leukemia in blast crisis, leukemia evolving from therapy-related myelodysplasia, and with leukemia following other hematopoietic proliferative diseases. The t(3;21) is rare secondary aberration in blast crisis of Philadelphia(Ph)-positive chronic myeloid leukemia, which may be restricted to patients entering myeloid blast crisis. We report here in one case of chronic myeloid leukemia in blast crisis which reveals both t(9;22) (q34;q11), and t(3;21) (q26 ;q22). A 62-year-old male was diagnosed as chronic myeloid leukemia 5 years ago, received hydroxyurea therapy, and admitted because of gingival bleeding and fever. On examination, splenomegaly and leukocytosis with proliferated blasts(91%) in peripheral blood were noted. Bone marrow aspirate showed hypercellularity with severe blast proliferation(92.5%) which revealed all negative in peroxidase and PAS stain. Cytogenetic study of bone marrow cells showed the karyotype 46, XY, t(3;21) (q26;q22), t(9;22) (q34;q11), which might be suspected as myeloid blast crisis. Above finding was confirmed by the result of immunophenotyping(CD13 43.6%, CD34 68.2%, HLA-DR 91.6%). He received intensive chemotherapy, but still sustained proliferation of blasts was noted . The follow up cytogenetic study was as follows: 46, XY, 4(3;21) (q26:22), t(9;22) (q34;q11)/46, XY, t(3;21)(q26;q22), del(8) (q22), t(9:22) (q34,q11)/46, XY (16/3/1). He died soon from severe pancytopenia and sepsis.
Blast Crisis*
;
Bone Marrow
;
Bone Marrow Cells
;
Cytogenetics
;
Drug Therapy
;
Fever
;
Follow-Up Studies
;
Hemorrhage
;
HLA-DR Antigens
;
Humans
;
Hydroxyurea
;
Karyotype
;
Leukemia
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
;
Leukocytosis
;
Male
;
Middle Aged
;
Pancytopenia
;
Peroxidase
;
Sepsis
;
Splenomegaly
2.Clinical application of therapeutic plasma exchange.
Dong Seok JEON ; Bok Cheol HWANG ; Hyo Jin CHUN ; Jay Ryong KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1991;2(2):175-181
No abstract available.
Plasma Exchange*
;
Plasma*
3.Acute Lymphoblastic Leukemia with Philadelphia Chromosome and Monosomy 7.
Gui Jeon CHOI ; Hyo Jin CHUN ; Dong Seok JEON ; Jae Ryong KIM ; Myung Soo HYUN
Korean Journal of Clinical Pathology 1997;17(4):519-529
BACKGROUND: The combination of Philadelphia chromosome (Ph) and monosomy 7(-7) was rarely observed in acute lymphoblastic leukemia (ALL). With the results from immunophenotyplc and molecular analysis, Philadelphia chromosome positive ALL with monosomy 7[Ph(+)/-7] has been considered that it may be derived from neoplastic transformation at the pluripotent stem cell level. We compared the clini-cal, laboratory, and hematological findings between 5 cases of Ph(+)/-7 and 5 cases of Ph(+) without monosomy 7 [Ph (+) /N7]. METHODS: During the period from January, 1995 to December, 1996, total 72 cases of ALL were confirmed among 259 cases of hematologic malignancy with bone marrow cytogenetic analysis. Among 72 ALL cases, 5 cases of Ph(+)/-7(monosomy 7 or 7q abnormalities) were compared with Ph only or Ph without monosomy 7(ph(+)/N7] on the hematological, immunophenotypic, other laboratory, clinical findings and event ree survival (EFS) The karyotyping of the bone marrow specimens was analysed byshort-term unsynchronized culture methods such as overnight colcemid treatment and 24 hours incubation following ethidium bromide treatment. RESULTS: The mean age of Ph(+)/-7 was 30.6+/-12.8 years, and it was significantly different from that of Ph(+)/N7 (p=0.009), Four cases of Ph(+)/-7 were classified as ALL L2 subtype, and 2 cases revealed CNS involvements. Immunophenotyping was positive in CD10, CDl9, CD2O, CD22 and HLA-DR. But one case revealed e-B-lymphoid lineage with positivity in CD34, CDl3, and CD33. The response to chemotherapy and EFS was very poor in Ph(+)/-7 group, and the mean EFS was 3.2+/-1.9 months(p=0.014). All of cases showed induction on failure in chemotherapy, relapsed with bone marrow, CNS and extramedullary involvements, and expired due to sepsis. CONCLUSIONS: Ph(+)/-7 ALL had very Poor clinical course with being resistant to chemotherapy and unfavorable prognosis, revealed L2 subtype by FAB classification, and was slightly older in ages compared with Ph(+)/N7 ALL.
Bone Marrow
;
Classification
;
Cytogenetic Analysis
;
Demecolcine
;
Drug Therapy
;
Ethidium
;
Hematologic Neoplasms
;
HLA-DR Antigens
;
Hydrogen-Ion Concentration
;
Immunophenotyping
;
Karyotyping
;
Monosomy*
;
Philadelphia Chromosome*
;
Pluripotent Stem Cells
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Prognosis
;
Sepsis
4.Effects of plateletpheresis on platelet aggregation in healthy donors.
Heon Chan PARK ; Hyo Jin CHUN ; Dong Seok JEON ; Jae Ryong KIM ; Sang Kyun PARK
Korean Journal of Blood Transfusion 1993;4(1):55-60
No abstract available.
Blood Platelets*
;
Humans
;
Platelet Aggregation*
;
Plateletpheresis*
;
Tissue Donors*
5.Analysis of blood transfused for past five years at Dongsan hospital.
Soo Jin PARK ; Dong Seok JEON ; Hyo Jin CHUN ; Jae Ryong KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1993;4(2):181-186
No abstract available.
6.Analysis of blood transfused for past five years at Dongsan hospital.
Soo Jin PARK ; Dong Seok JEON ; Hyo Jin CHUN ; Jae Ryong KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1993;4(2):181-186
No abstract available.
7.Analysis of 107 cases of chromosomal abnormalities.
Young Jae KIM ; Hyo Jin CHUN ; Dong Seok JEON ; Jae Ryong KIM ; Gyoung Yim HA
Korean Journal of Clinical Pathology 1992;12(4):513-522
No abstract available.
Chromosome Aberrations*
8.Transferrin Analysis by Immunofixation for The Diagnosis of Cerebrospinal Fluid Leakage.
Moon Hee LEE ; Dong Seok JEON ; Hyo Jin CHUN ; Jae Ryong KIM
Korean Journal of Clinical Pathology 1999;19(1):46-51
BACKGROUND: CSF can be leaked from the nose or ear due to fractures, tumors or surgical procedures in the skull base region, and the threat of impending meningitis necessitates early identification of it. Since 2-transferrin occurs practically in cerebrospinal fluid (CSF) and not in other body fluid, its detection from the rhinorrhea or otorrhea can be used for the diagnosis of CSF leakage. We carried out immunofixation-silver stain (IF-SS) method for detection of 2-transferrin in the CSF in order to know optimal identification condition of specific cerebrogenic marker. METHODS: The fresh CSF sample was collected by spinal tapping. 2-Transferrin was estimated by quantifying the total transferrin by nephelomertry (Behring, Germany). 2-Transferrin of CSF was identified by electrophoresis using Titan gel high resolution protein system (Beckman, USA), immunofixation with anti-human transferrin antibody (Dako, Denmark) and then stained with silver nitrate. Serial dilutions of CSF were performed to know the detection limit of 2-transferrin. To know the influence of blood mixing, tests for mixed specimen of serum and hemolysate in CSF were performed. To evaluate the specimen storage condition, tests for different temperature and storage time were performed . RESULTS: By IF-SS method, identification limit of 2-transferrin was 0.5 mg/dL in 1:4 diluted CSF with distilled water. And 2-transferrin could be detected in condition of mixing serum protein (7.5 g/dL) or hemoglobin (13 g/dL) with CSF up to 6 : 4. At various sample storage condition, such as 37degrees C, room temperature, and 4degrees C, band intensity decreased abruptly after 1 day, and it was not detected 5 days later. Mean while, in -20degrees C and -70degrees C, 2-transferin band was detected after 10 days. CONCLUSIONS: IF-SS method was sufficiently sensitive and specific for invalidation by blood contamination, and seems to be used as effective identification of 2-transferrin in the CSF without sample concentration, less diagnostic test for CSF leakage.
Body Fluids
;
Cerebrospinal Fluid*
;
Diagnosis*
;
Diagnostic Tests, Routine
;
Ear
;
Electrophoresis
;
Limit of Detection
;
Meningitis
;
Nose
;
Saturn
;
Silver Nitrate
;
Skull Base
;
Spinal Puncture
;
Transferrin*
;
Water
9.Changes of fibrinogen and coagulation factor NIII in cryoprecipitate according to storage temperature and time after thawing.
Young Jae KIM ; Hyo Jin CHUN ; Dong Seok JEON ; Jae Pyong KIM ; Dal Hyo SONG
Korean Journal of Clinical Pathology 1992;12(3):395-400
No abstract available.
Blood Coagulation Factors*
;
Fibrinogen*
10.Changes of fibrinogen and coagulation factor NIII in cryoprecipitate according to storage temperature and time after thawing.
Young Jae KIM ; Hyo Jin CHUN ; Dong Seok JEON ; Jae Pyong KIM ; Dal Hyo SONG
Korean Journal of Clinical Pathology 1992;12(3):395-400
No abstract available.
Blood Coagulation Factors*
;
Fibrinogen*